Physician

Gerald T Ware, M.D.

According to 2025 Medicare claims, Gerald Ware, M.D. (NPI: 1851373484) practices ophthalmology in the Little Rock-North Little Rock-Conway, AR market, with the plurality of this provider's patient population coming from Pulaski, AR. This provider's primary affiliated billing organization is RETINA ASSOCIATES, P.A. (NPI: 1447215603; TIN: 71-0706742) and primary practice location at 72205-6243.

Ware's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 911 traditional Medicare patients, billed 24,025 HCPCS/CPT codes, and received $2,196,609 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 316 prescription claims across 109 beneficiaries totaling $9,819 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 15 records totaling $936. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,360,747 to $2,196,609. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $14,859 to $9,819. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.3M2015 Medicare payment: $1,360,747 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,560,247 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,496,866 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,660,427 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,287,378 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,175,345 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,149,035 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,090,476 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,070,401 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,196,609 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,34312,691$1,360,747
20161,49815,610$1,560,247
20171,46514,173$1,496,866
20181,41213,710$1,660,427
20191,82816,385$2,287,378
20201,51113,831$2,175,345
20211,28213,238$2,149,035
20221,19213,542$2,090,476
20231,06421,486$2,070,401
202491124,025$2,196,609

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$31K$62K2015 Drug cost: $14,859 (USD; Tot_Drug_Cst)2016 Drug cost: $62,479 (USD; Tot_Drug_Cst)2017 Drug cost: $20,205 (USD; Tot_Drug_Cst)2018 Drug cost: $20,767 (USD; Tot_Drug_Cst)2019 Drug cost: $15,951 (USD; Tot_Drug_Cst)2020 Drug cost: $22,807 (USD; Tot_Drug_Cst)2021 Drug cost: $14,450 (USD; Tot_Drug_Cst)2022 Drug cost: $10,210 (USD; Tot_Drug_Cst)2023 Drug cost: $10,180 (USD; Tot_Drug_Cst)2024 Drug cost: $9,819 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015107325$14,859
2016137366$62,479
2017128359$20,205
2018128299$20,767
2019137320$15,951
2020135345$22,807
2021100266$14,450
202295208$10,210
202398230$10,180
2024109316$9,819

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye4171,626$79
92014Established patient complete exam of visual system649709$74
92012Established patient problem focused exam of visual system5751,593$56
92134Imaging of retina7662,172$25
92250Photography of the retina228257$23

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate602,190$3,107
Atropine SulfateAtropine Sulfate561,875$1,996
Ketorolac TromethamineKetorolac Tromethamine501,676$1,114
OfloxacinOfloxacin36757$474
Brimonidine TartrateBrimonidine Tartrate11750$195

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.15$936Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gerald T. Ware, M.D.?

Tedicare shows public-source Medicare data for Gerald T. Ware, M.D. (NPI 1851373484), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gerald T. Ware, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gerald T. Ware, M.D.?

Gerald T. Ware, M.D. is linked to RETINA ASSOCIATES, P.A. (billing NPI 1447215603) in the available physician profile data.

Does Gerald T. Ware, M.D. have Open Payments data?

Gerald T. Ware, M.D. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.